Acelot is a development stage biopharmaceutical company focused on therapies for Alzheimer’s Disease and neurodegenerative disorders.
Our novel machine learning and in vitro assay platform identifies small molecules that act specifically upon toxic forms of proteins found in neurodegenerative diseases.
CEO, MBA, PhD
Leader in building data-driven biotech companies
Director of Research, Preclinical, PhD
Neurodegenerative preclinical research expert
UCSB Computer Science Professor with research expertise in machine learning applied to biology and chemistry
Data Scientist, MS
Software and machine learning expert